Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nuclear factor NF-kappa-B p105 subunit, encoded by the NFKB1 gene, is a key regulator of immune response, inflammation, cell survival, and development. The full-length 105 kDa protein (p105) serves as both an inhibitor and precursor within the NF-κB signaling pathway. It is processed to generate the active p50 subunit. NFKB1 is highly expressed in macrophages and many tissues involved in immunity. As part of heterodimers (e.g., with RelA/p65), it regulates genes involved in immunity and inflammation. Loss-of-function mutations can cause immunodeficiencies, while overactivation is linked to chronic inflammatory diseases.
Modulation of NF-κB signaling pathway, typically through inhibition of IKK complex or direct inhibition of NF-κB dimers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor NF-kappa-B p105 subunit (NFKB1).